¼Òº¯ °Ë»ç ½ÃÀå ±Ô¸ð - Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ¼¼°è ¿¹Ãø(2023-2032³â)
Urinalysis Market Size - By Product (Consumables, Instruments), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-Use (Clinical Laboratories, Hospitals, Home Healthcare), Global Forecast 2023 - 2032
»óǰÄÚµå
:
1351550
¸®¼Ä¡»ç
:
Global Market Insights Inc.
¹ßÇàÀÏ
:
2023³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 200 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°è ¼Òº¯ °Ë»ç ½ÃÀåÀº 2023³âºÎÅÍ 2032³â±îÁö CAGR 5.2%¸¦ ±â·ÏÇÒ °ÍÀÔ´Ï´Ù.
ÀÌ·¯ÇÑ ¹è°æ¿¡´Â ¿ä·Î °¨¿°°ú ½ÅÀå ÁúȯÀÇ Áõ°¡°¡ ÀÖ½À´Ï´Ù.
CDC¿¡ µû¸£¸é, ¹Ì±¹¿¡´Â ¾à 3,550¸¸ ¸íÀÇ ¼ºÀÎÀÌ ¸¸¼º ½ÅÀå ÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ÀÌ´Â Áø´Ü µµ±¸·Î¼ ¼Òº¯ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î °í·ÉȰ¡ ÁøÇàµÇ¸é¼ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, Á¤±âÀûÀÎ ¼Òº¯ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù. °Ç° °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àû±ØÀûÀÎ ¿¹¹æÀû ÀÇ·á ´ëÃ¥ÀÌ Á¤±âÀûÀÎ ¼Òº¯ °Ë»çÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®Ãæ°ú Áúº´ Á¶±â ¹ß°ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå È®´ë°¡ ´õ¿í °¡¼Ó鵃 °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¼Òº¯ °Ë»ç´Â Çö´ë ÀÇ·áÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.
Àüü ¼Òº¯ °Ë»ç ½ÃÀåÀº Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.
Á¦Ç°º°·Î´Â ±â±â ºÎ¹®ÀÌ 2023³âºÎÅÍ 2032³â±îÁö 6.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿ä·Î °¨¿° ¹× ¸¸¼º ½ÅÀå ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Áúº´ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼Òº¯ °Ë»ç Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÈÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
´ç´¢º´ ÀÀ¿ë ºÐ¾ßÀÇ ¼Òº¯ °Ë»ç »ê¾÷Àº 2023³âºÎÅÍ 2032³â±îÁö 9.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ´ç´¢º´ÀÇ È®»êÀº ÇâÈÄ ¸î ³â µ¿¾È ÀÌ ºÎ¹® ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ´ç´¢º´ ȯÀÚÀÇ Áõ°¡´Â ¿ä´ç ¹× ÄÉÅæÃ¼ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ´ç´¢º´ °ü¸® ¹× ¸ð´ÏÅ͸µ¿¡¼ ¼Òº¯ °Ë»çÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °Á¶Çϰí ÀÖ½À´Ï´Ù.
ÃÖÁ¾ ¿ëµµº°·Î º¸¸é ÀÓ»ó ½ÇÇè½Ç ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 5.9%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤±â °Ç° °ËÁø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Áúº´ À¯º´·ü Áõ°¡, Áø´Ü ±â¼ú ¹ßÀü, ¿¹¹æÀû °Ç° °ü¸® Ãß¼¼ Áõ°¡´Â ÀÓ»ó ½ÇÇè½Ç¿¡¼ ¼Òº¯ °Ë»ç ÀýÂ÷ÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.
Áö¿ªº°·Î º¸¸é ¶óƾ¾Æ¸Þ¸®Ä«(LATAM)ÀÇ ¼Òº¯ °Ë»ç »ê¾÷Àº 2023³âºÎÅÍ 2032³â±îÁö CAGR 4.3%·Î ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù. ¼ºÀåÀÇ ¹è°æ¿¡´Â ÀÇ·á ÁöÃâ Áõ°¡¿Í ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë°¡ ÀÖ½À´Ï´Ù. °í·ÉÈ Àα¸ÀÇ Áõ°¡, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¸¸¼º Áúȯ ¹ßº´·ü Áõ°¡µµ ÀÌ Áö¿ªÀÇ ¼Òº¯ °Ë»ç ¹× ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼Òº¯ °Ë»ç ¾÷°è ÀλçÀÌÆ®
- »ýÅÂ°è ºÐ¼®
- ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
- ¼ºÀå ÃËÁø¿äÀÎ
- °³¹ßµµ»ó Áö¿ªÀÇ ¿ä·Î°¨¿°Áõ Áõ°¡
- ¼¼°èÀÇ ¸¸¼º ½ÅÀ庴 À¯º´·ü Áõ°¡
- ³ëÀÎ Àα¸ Áõ°¡
- ³ôÀº ÀÓ½ÅÀ²
- ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
- Á¤±â °ËÁø¿¡ ´ëÇÑ ³·Àº ÀǽÄ
- ±â±â °³¹ß¿¡ °É¸®´Â ³ôÀº ¿¬±¸°³¹ßºñ
- ¼ºÀå °¡´É¼º ºÐ¼®
- COVID-19 ¿µÇ⠺м®
- ±ÔÁ¦ »óȲ
- Porters ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå °æÀï »óȲ
- ¼·Ð
- ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
- °æÀï ´ë½Ãº¸µå
- ±â¾÷ Á¡À¯À² ºÐ¼®
- º¥´õ ¸ÅÆ®¸¯½º ºÐ¼®
- ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
- °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
- Àü·« Àü¸Á ¸ÅÆ®¸¯½º
Á¦5Àå ¼Òº¯ °Ë»ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°
- ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
- ¼Ò¸ðǰ
- ºÐ¼® ±â±â
- »ýÈÇÐ ¼Òº¯ ºÐ¼®±â
- ÀÚµ¿ ¼Òº¯ ħÀü¹° ºÐ¼®±â
Á¦6Àå ¼Òº¯ °Ë»ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°
- ÁÖ¿ä µ¿Çâ : ¿ëµµº°
- ¿ä·Î°¨¿°Áõ(UTI)
- ½ÅÀå Áúȯ
- ÀÓ½Å
- ´ç´¢º´
- ±âŸ
Á¦7Àå ¼Òº¯ °Ë»ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°
- ÁÖ¿ä µ¿Çâ : ÃÖÁ¾ ¿ëµµº°
- ÀÓ»ó °Ë»ç½Ç
- º´¿ø
- ÀçÅà ÇコÄɾî
- ±âŸ
Á¦8Àå ¼Òº¯ °Ë»ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
- ÁÖ¿ä µ¿Çâ : Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ³×´ú¶õµå
- Æú¶õµå
- µ§¸¶Å©
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- È£ÁÖ
- Çѱ¹
- Àεµ³×½Ã¾Æ
- º£Æ®³²
- Çʸ®ÇÉ
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- ÄÝ·Òºñ¾Æ
- Ä¥·¹
- Æä·ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- ÀÌÁýÆ®
- ÅÍŰ
Á¦9Àå ±â¾÷ °³¿ä
- Sysmex Corporation
- F. Hoffmann-La Roche Ltd
- ACON Laboratories, Inc.
- Cardinal Health
- Abbott Laboratories
- Bio-Rad Laboratories, Inc
- ARKRAY, Inc.
- Erba Mannheim
- Siemens Healthineers
- Teco Diagnostics
- Elektronika Kft.
ksm
¿µ¹® ¸ñÂ÷
Global urinalysis market will reflect 5.2% CAGR over 2023-2032. This is attributed to the increasing prevalence of urinary tract infections and kidney diseases.
According to the CDC, nearly 35.5 million adults in the U.S. suffer from chronic kidney disease. This is propelling the demand for urinalysis tests as a diagnostic tool which will propel market growth. The aging global population is also contributing to a higher incidence of chronic diseases, necessitating regular urine monitoring. Rising healthcare awareness and proactive preventive healthcare measures are further boosting the adoption of routine urine testing. Expanding healthcare infrastructure in developing regions and the growing emphasis on early disease detection may further drive market expansion, making urinalysis a vital component of modern healthcare.
The overall urinalysis market is categorized based on product, application, end-use and region.
Based on product, the instrument segment will exhibit a 6.4% CAGR from 2023 to 2032. Growing awareness about the importance of early disease detection alongside the increasing prevalence of urinary tract infections and chronic kidney diseases will fuel demand for urinalysis instruments, accelerating segment growth.
Urinalysis industry from the diabetes application segment is expected to witness a 9.3% CAGR from 2023 to 2032. The escalating global diabetes epidemic will drive the segment growth in the forthcoming years. Increasing diabetic patient populations are boosting the demand for urine glucose and ketone testing, emphasizing the vital role of urinalysis in diabetes management and monitoring.
By end-use, clinical laboratories segment is expected to grow at a 5.9% CAGR throughout the forecast period. The increasing demand for routine health check-ups, rising disease prevalence, advancements in diagnostic technology, and the growing trend towards preventive healthcare will drive the adoption of urinalysis procedures in clinical laboratories.
Regionally, the Latin American (LATAM) urinalysis industry will grow at a 4.3% CAGR from 2023 to 2032. The growth is attributed to rising healthcare expenditure and expanding access to healthcare services. An increase in the aging population, growing awareness of preventive healthcare, and the rising incidence of chronic diseases are also boosting demand for urinalysis tests and services in the region.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.3 Forecast calculations
- 1.4 COVID-19 impact analysis at global level
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Urinalysis industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.2 Business trends
- 2.3 Regional trends
- 2.4 Product trends
- 2.5 Application trends
- 2.6 End-use trends
Chapter 3 Urinalysis Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing incidence of urinary tract infection in developing regions
- 3.2.1.2 Increasing prevalence of chronic kidney disease worldwide
- 3.2.1.3 Increasing geriatric population
- 3.2.1.4 High pregnancy rates
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Low awareness about routine check-ups
- 3.2.2.2 High R&D cost of developing instruments
- 3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-use
- 3.4 COVID- 19 impact analysis
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
- 4.1 Introduction
- 4.2 Company matrix analysis, 2022
- 4.3 Competitive dashboard, 2022
- 4.4 Company market share analysis, 2022
- 4.5 Vendor matrix analysis, 2022
- 4.6 Competitive analysis of major market players
- 4.7 Competitive positioning matrix
- 4.8 Strategic outlook matrix
Chapter 5 Urinalysis Market Size and Forecast, By Product (USD Million)
- 5.1 Key trends, by product
- 5.2 Consumables
- 5.2.1 Dipsticks
- 5.2.2 Reagents
- 5.2.3 Dsiposables
- 5.3 Instruments
- 5.3.1 Biochemical urine analyzer
- 5.3.2 Automated urine sediment analyzer
Chapter 6 Urinalysis Market Size and Forecast, By Application (USD Million)
- 6.1 Key trends, by application
- 6.2 Urinary tract infections (UTI)
- 6.3 Kidney diseases
- 6.4 Pregnancy
- 6.5 Diabetes
- 6.6 Others
Chapter 7 Urinalysis Market Size and Forecast, By End-use (USD Million)
- 7.1 Key trends, by end-use
- 7.2 Clinical laboratories
- 7.3 Hospitals
- 7.4 Home healthcare
- 7.5 Others
Chapter 8 Urinalysis Market Size and Forecast, By Region (USD Million)
- 8.1 Key trends, by region
- 8.2 North America
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 The Netherlands
- 8.3.7 Poland
- 8.3.8 Denmark
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Vietnam
- 8.4.8 Philippines
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
- 8.5.5 Chile
- 8.5.6 Peru
- 8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Turkey
Chapter 9 Company Profiles
- 9.1 Sysmex Corporation
- 9.2 F. Hoffmann-La Roche Ltd
- 9.3 ACON Laboratories, Inc.
- 9.4 Cardinal Health
- 9.5 Abbott Laboratories
- 9.6 Bio-Rad Laboratories, Inc
- 9.7 ARKRAY, Inc.
- 9.8 Erba Mannheim
- 9.9 Siemens Healthineers
- 9.10 Teco Diagnostics
- 9.11 Elektronika Kft.
°ü·ÃÀÚ·á